Organon (OGN) Times Interest Earned (2020 - 2026)
Organon (OGN) posted quarterly Times Interest Earned of $2.99 for Q2 2026, up 20.92% year-over-year from $2.47 in Q2 2025, and up 41.26% on a QoQ basis from $2.12 in Q1 2026.
Organon (OGN) Times Interest Earned (2020 - 2026) Analysis & Trends
Organon has reported Times Interest Earned for 6 years, with the latest figure at $2.99 in Q2 2026.
- Times Interest Earned for Q2 2026 came in at $2.99, up 20.92% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.41 (down 2.2% YoY), and the FY2025 annual result was $2.24, down 19.8% from the prior year.
- Times Interest Earned grew to $2.99 in Q2 2026, from $2.12 in the prior quarter.
- Over five years, Times Interest Earned peaked at $3.26 in Q3 2024 and troughed at -$4.49 in Q4 2023.
- A 5-year average of -$0.28 and a median of $0.37 in 2022 frame the typical range for Times Interest Earned.
- The widest annual swing landed in 2022, when Times Interest Earned tumbled 255.5%; it then soared 200.76% in 2024.
- A 5-year view of Times Interest Earned shows it stood at -$4.06 in 2022, then decreased by 10.58% to -$4.49 in 2023, then surged by 148.61% to $2.18 in 2024, then slipped by 20.45% to $1.74 in 2025, then surged by 72.32% to $2.99 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were $2.99 in Q2 2026, $2.12 in Q1 2026, and $1.74 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -2.64 |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 2.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.99 |
| Mar 31, 2026 | 2.12 |
| Dec 31, 2025 | 1.74 |
| Sep 30, 2025 | 2.80 |
| Jun 30, 2025 | 2.47 |
| Mar 31, 2025 | 1.93 |
| Dec 31, 2024 | 2.18 |
| Sep 30, 2024 | 3.26 |
| Jun 30, 2024 | 2.95 |
| Mar 31, 2024 | -3.27 |
| Dec 31, 2023 | -4.49 |
| Sep 30, 2023 | -3.97 |
| Jun 30, 2023 | -2.92 |
| Mar 31, 2023 | -2.61 |
| Dec 31, 2022 | -4.06 |
| Sep 30, 2022 | -2.49 |
| Jun 30, 2022 | -2.66 |
| Mar 31, 2022 | -1.23 |
| Dec 31, 2021 | -3.70 |
| Sep 30, 2021 | -1.69 |